HIGHLIGHTS
- who: Marie Morel and colleagues from the Queen Mary University of London, United Kingdom have published the article: Abnormal B cell glycosylation in autoimmunity: A new potential treatment strategy, in the Journal: (JOURNAL)
- what: They can also alter the transduced signals from the BCR to the cells directly or indirectly by perturbing the activity of inhibitory proteins such Another ELISA-derived assay was optimised to focus on IgA1, IgA2 and IgG to further the investigations .
- how: Data were analysed using Kaluza 2.1 software (Beckman Coulter Brea CA USA). These results were expected . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.